Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017
Descripción del Articulo
Worldwide, conjugated pneumococcal vaccines (PCVs) have proven effective against invasive pneumococcal disease, but non-invasive pneumonia is a major cause of mortality in young children and serotypes vary geographically, affecting effectiveness. We analyze nationwide death certificate data between...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2023 |
| Institución: | Universidad Peruana de Ciencias Aplicadas |
| Repositorio: | UPC-Institucional |
| Lenguaje: | inglés |
| OAI Identifier: | oai:repositorioacademico.upc.edu.pe:10757/673133 |
| Enlace del recurso: | http://hdl.handle.net/10757/673133 |
| Nivel de acceso: | acceso abierto |
| Materia: | herd immunity Peru pneumococcal conjugate vaccine pneumonia Streptococcus pneumoniae https://purl.org/pe-repo/ocde/ford#3.00.00 |
| id |
UUPC_c14fe38de48aa54ae81db97128668f43 |
|---|---|
| oai_identifier_str |
oai:repositorioacademico.upc.edu.pe:10757/673133 |
| network_acronym_str |
UUPC |
| network_name_str |
UPC-Institucional |
| repository_id_str |
2670 |
| dc.title.es_PE.fl_str_mv |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| title |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| spellingShingle |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 Sanchez, Carlos A. herd immunity Peru pneumococcal conjugate vaccine pneumonia Streptococcus pneumoniae https://purl.org/pe-repo/ocde/ford#3.00.00 |
| title_short |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| title_full |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| title_fullStr |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| title_full_unstemmed |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| title_sort |
Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017 |
| author |
Sanchez, Carlos A. |
| author_facet |
Sanchez, Carlos A. Lozada-Urbano, Michelle Best-Bandenay, Pablo |
| author_role |
author |
| author2 |
Lozada-Urbano, Michelle Best-Bandenay, Pablo |
| author2_role |
author author |
| dc.contributor.author.fl_str_mv |
Sanchez, Carlos A. Lozada-Urbano, Michelle Best-Bandenay, Pablo |
| dc.subject.es_PE.fl_str_mv |
herd immunity Peru pneumococcal conjugate vaccine pneumonia Streptococcus pneumoniae |
| topic |
herd immunity Peru pneumococcal conjugate vaccine pneumonia Streptococcus pneumoniae https://purl.org/pe-repo/ocde/ford#3.00.00 |
| dc.subject.ocde.none.fl_str_mv |
https://purl.org/pe-repo/ocde/ford#3.00.00 |
| description |
Worldwide, conjugated pneumococcal vaccines (PCVs) have proven effective against invasive pneumococcal disease, but non-invasive pneumonia is a major cause of mortality in young children and serotypes vary geographically, affecting effectiveness. We analyze nationwide death certificate data between 2003–2017 to assess the impact of PCVs on pneumonia mortality among young children from Peru. We report descriptive statistics and perform timeseries analysis on annual mortality rates (AMRs) and monthly frequencies of pneumonia deaths. Children under 5 years of age accounted for 6.2% (n = 10,408) of all pneumonia deaths (N = 166,844), and 32.3% (n = 3363) were children between 1–4 years of age, of which 95.1% did not report pneumonia etiology. Comparing periods before and after PCV introduction in 2009, mean AMRs dropped 13.5% and 26.0% for children between 1–4 years of age (toddlers/preschoolers), and children under 1 year of age (infants), respectively. A moderate correlation (Spearman’s r = 0.546, p < 0.01) in the monthly frequency of pneumonia deaths was estimated between both age groups. Quadratic regression suggests a change in direction around 2005 (highest pneumonia mortality) for both age groups, but percentage change analysis identified an inflection point in 2013 for infants only, not for toddlers/preschoolers, suggesting that the impact of PCVs might be different for each age group. |
| publishDate |
2023 |
| dc.date.accessioned.none.fl_str_mv |
2024-03-20T15:57:56Z |
| dc.date.available.none.fl_str_mv |
2024-03-20T15:57:56Z |
| dc.date.issued.fl_str_mv |
2023-11-01 |
| dc.type.es_PE.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.doi.none.fl_str_mv |
10.3390/vaccines11111715 |
| dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10757/673133 |
| dc.identifier.eissn.none.fl_str_mv |
2076393X |
| dc.identifier.journal.es_PE.fl_str_mv |
Vaccines |
| dc.identifier.eid.none.fl_str_mv |
2-s2.0-85178313661 |
| dc.identifier.scopusid.none.fl_str_mv |
SCOPUS_ID:85178313661 |
| dc.identifier.isni.none.fl_str_mv |
0000 0001 2196 144X |
| dc.identifier.ror.none.fl_str_mv |
047xrr705 |
| identifier_str_mv |
10.3390/vaccines11111715 2076393X Vaccines 2-s2.0-85178313661 SCOPUS_ID:85178313661 0000 0001 2196 144X 047xrr705 |
| url |
http://hdl.handle.net/10757/673133 |
| dc.language.iso.es_PE.fl_str_mv |
eng |
| language |
eng |
| dc.rights.es_PE.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.*.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.format.es_PE.fl_str_mv |
application/pdf |
| dc.publisher.es_PE.fl_str_mv |
MDPI |
| dc.source.es_PE.fl_str_mv |
Universidad Peruana de Ciencias Aplicadas (UPC) Repositorio Academico - UPC |
| dc.source.none.fl_str_mv |
reponame:UPC-Institucional instname:Universidad Peruana de Ciencias Aplicadas instacron:UPC |
| instname_str |
Universidad Peruana de Ciencias Aplicadas |
| instacron_str |
UPC |
| institution |
UPC |
| reponame_str |
UPC-Institucional |
| collection |
UPC-Institucional |
| dc.source.journaltitle.none.fl_str_mv |
Vaccines |
| dc.source.volume.none.fl_str_mv |
11 |
| dc.source.issue.none.fl_str_mv |
11 |
| bitstream.url.fl_str_mv |
https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/5/vaccines-11-01715-v2.pdf.jpg https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/4/vaccines-11-01715-v2.pdf.txt https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/3/license.txt https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/2/license_rdf https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/1/vaccines-11-01715-v2.pdf |
| bitstream.checksum.fl_str_mv |
6103e92615f10ac54c3ae7baa963c6c8 09cd1b3f1847e24ed65fb26d9a21a4aa 8a4605be74aa9ea9d79846c1fba20a33 4460e5956bc1d1639be9ae6146a50347 d483da5b535e5ef730f541cef096ca6c |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Académico UPC |
| repository.mail.fl_str_mv |
upc@openrepository.com |
| _version_ |
1851775505234132992 |
| spelling |
dced83d2bb0b8f2b650a88a140bf970c500a110004d2f308c6dd9aeb883822ea0a26c2c20f2b1a48cefe7e81cb802c23d9dSanchez, Carlos A.Lozada-Urbano, MichelleBest-Bandenay, Pablo2024-03-20T15:57:56Z2024-03-20T15:57:56Z2023-11-0110.3390/vaccines11111715http://hdl.handle.net/10757/6731332076393XVaccines2-s2.0-85178313661SCOPUS_ID:851783136610000 0001 2196 144X047xrr705Worldwide, conjugated pneumococcal vaccines (PCVs) have proven effective against invasive pneumococcal disease, but non-invasive pneumonia is a major cause of mortality in young children and serotypes vary geographically, affecting effectiveness. We analyze nationwide death certificate data between 2003–2017 to assess the impact of PCVs on pneumonia mortality among young children from Peru. We report descriptive statistics and perform timeseries analysis on annual mortality rates (AMRs) and monthly frequencies of pneumonia deaths. Children under 5 years of age accounted for 6.2% (n = 10,408) of all pneumonia deaths (N = 166,844), and 32.3% (n = 3363) were children between 1–4 years of age, of which 95.1% did not report pneumonia etiology. Comparing periods before and after PCV introduction in 2009, mean AMRs dropped 13.5% and 26.0% for children between 1–4 years of age (toddlers/preschoolers), and children under 1 year of age (infants), respectively. A moderate correlation (Spearman’s r = 0.546, p < 0.01) in the monthly frequency of pneumonia deaths was estimated between both age groups. Quadratic regression suggests a change in direction around 2005 (highest pneumonia mortality) for both age groups, but percentage change analysis identified an inflection point in 2013 for infants only, not for toddlers/preschoolers, suggesting that the impact of PCVs might be different for each age group.Revisión por paresODS 3: Salud y bienestarODS 9: Industria, innovación e infraestructuraODS 17: Alianzas para lograr los objetivosapplication/pdfengMDPIinfo:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Academico - UPCVaccines1111reponame:UPC-Institucionalinstname:Universidad Peruana de Ciencias Aplicadasinstacron:UPCherd immunityPerupneumococcal conjugate vaccinepneumoniaStreptococcus pneumoniaehttps://purl.org/pe-repo/ocde/ford#3.00.00Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017info:eu-repo/semantics/article2024-03-20T15:57:58ZTHUMBNAILvaccines-11-01715-v2.pdf.jpgvaccines-11-01715-v2.pdf.jpgGenerated Thumbnailimage/jpeg98108https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/5/vaccines-11-01715-v2.pdf.jpg6103e92615f10ac54c3ae7baa963c6c8MD55falseTEXTvaccines-11-01715-v2.pdf.txtvaccines-11-01715-v2.pdf.txtExtracted texttext/plain44717https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/4/vaccines-11-01715-v2.pdf.txt09cd1b3f1847e24ed65fb26d9a21a4aaMD54falseLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53falseCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52falseORIGINALvaccines-11-01715-v2.pdfvaccines-11-01715-v2.pdfapplication/pdf5018628https://repositorioacademico.upc.edu.pe/bitstream/10757/673133/1/vaccines-11-01715-v2.pdfd483da5b535e5ef730f541cef096ca6cMD51true10757/673133oai:repositorioacademico.upc.edu.pe:10757/6731332025-10-30 07:42:06.577Repositorio Académico UPCupc@openrepository.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 |
| score |
13.39529 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).